These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23696179)

  • 1. Establishing benchmark rates of microbial and bacterial endotoxin contamination for radiopharmaceuticals compounded in commercial nuclear pharmacy settings.
    Weatherman KD; Augustine S; Christoff J; Galbraith W
    Int J Pharm Compd; 2013; 17(2):168-74. PubMed ID: 23696179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limulus amebocyte lysate testing: adapting it for determination of bacterial endotoxin in 99mTc-labeled radiopharmaceuticals at a hospital radiopharmacy.
    Mitra A; Joshi S; Arjun C; Kulkarni S; Rajan R
    J Nucl Med Technol; 2014 Dec; 42(4):278-82. PubMed ID: 25472516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated endotoxin testing program for high-risk-level compounded sterile preparations at an institutional compounding pharmacy.
    Cooper JF; Latta KS; Smith D
    Am J Health Syst Pharm; 2010 Feb; 67(4):280-6. PubMed ID: 20133532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Operation of a radiopharmacy for a clinical trial.
    Norenberg JP; Petry NA; Schwarz S
    Semin Nucl Med; 2010 Sep; 40(5):347-56. PubMed ID: 20674594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of compounded bevacizumab prepared for intravitreal injection.
    Yannuzzi NA; Klufas MA; Quach L; Beatty LM; Kaminsky SM; Crystal RG; D'Amico DJ; Kiss S
    JAMA Ophthalmol; 2015 Jan; 133(1):32-9. PubMed ID: 25233052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality-control analytical methods: endotoxins: essential testing for pyrogens in the compounding laboratory, part 3: a simplified endotoxin test method for compounded sterile preparations.
    Cooper JF
    Int J Pharm Compd; 2011; 15(1):49-54. PubMed ID: 23696047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality Control Testing for Tracking Endotoxin-Producing Gram-Negative Bacteria during the Preparation of Polyvalent Snake Antivenom Immunoglobulin.
    Sheraba NS; Diab MR; Yassin AS; Amin MA; Zedan HH
    PDA J Pharm Sci Technol; 2015; 69(4):499-510. PubMed ID: 26242786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the stability of common radiopharmaceuticals compounded and utilized outside package insert guidelines.
    Weatherman KD; Augustine S; Christoff J; Galbraith W
    Int J Pharm Compd; 2013; 17(3):238-46. PubMed ID: 24046939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Short time bacterial endotoxins test for positron emission tomography by means of positively charged filters].
    Nakazawa N; Wakita K; Mineura K; Nakamura M; Fujii R; Nakanishi H; Uji Y; Matsuura S; Itani K; Kanatsuna T; Ido T; Imahori Y
    Kaku Igaku; 2002 Nov; 39(4):543-8. PubMed ID: 12607243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of commercial nuclear pharmacy in the future practice of nuclear medicine.
    Callahan RJ
    Semin Nucl Med; 1996 Apr; 26(2):85-90. PubMed ID: 8723502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is your technetium generator eluate sterile?
    Snowdon GM
    J Nucl Med Technol; 2000 Jun; 28(2):94-5. PubMed ID: 10824620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus infections from a contaminated radiopharmaceutical used in myocardial perfusion studies.
    Patel PR; Larson AK; Castel AD; Ganova-Raeva LM; Myers RA; Roup BJ; Farrell KP; Edwards L; Nainan O; Krick JP; Blythe D; Fiore AE; Roche JC
    JAMA; 2006 Oct; 296(16):2005-11. PubMed ID: 17062864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strengthening radiopharmacy practice in IAEA Member States.
    Duatti A; Bhonsle U
    Semin Nucl Med; 2013 May; 43(3):188-94. PubMed ID: 23561456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Explanations and unresolved issues pertaining to the development of the Nuclear Pharmacy Compounding Guidelines.
    Hung JC; Augustine SC; Cheng KT; Green RL; Hopkins WM; Laven DL; Nelson BR; Petry NA; Ponto JA; Quinton TM; Swanson DP
    J Am Pharm Assoc (Wash); 2002; 42(5):789-98. PubMed ID: 12269713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compounding & dispensing errors before and after implementing barcode technology in a nuclear pharmacy.
    Galbraith W; Shadid J
    Int J Pharm Compd; 2012; 16(3):253-6. PubMed ID: 23050303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality Assurance and Quality Control, Part 2.
    Akers MJ
    Int J Pharm Compd; 2015; 19(3):215-21. PubMed ID: 26714362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End-preparation assessments and tests for compounded sterile preparations.
    McElhiney LF
    Int J Pharm Compd; 2013; 17(4):307-11. PubMed ID: 24261146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing of microbial contamination during the preparation of the radiocompound [⁹⁰Y]DOTATOC for clinical trials: a process validation study by Media Fill approach.
    Sirna V; Garaboldi L; Papi S; Martano L; Omodeo Salè E; Paganelli G; Chinol M
    Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):553-9. PubMed ID: 20927022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality Control of Compounded Crystalloid Fluids for Intravenous Delivery to Horses.
    Magnusson CB; Poulsen KP; Budde JA; Hartmann FA; Aulik NA; Raabis SM; Moreira ASD; Darien BJ; Peek SF
    J Vet Intern Med; 2018 Jan; 32(1):469-473. PubMed ID: 29114956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limulus test, parenteral drugs and biological products: an approach.
    Fumarola D; Jirillo E
    G Batteriol Virol Immunol; 1976; 69(1-6):34-8. PubMed ID: 1024849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.